Affordable Access

Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre study.

Authors
Type
Published Article
Journal
Antiviral therapy
Publication Date
Volume
12
Issue
7
Pages
1033–1040
Identifiers
PMID: 18018761
Source
Medline

Abstract

Despite the prevalence of moderators of treatment outcome, HCV-2 patients showed as high sustained virological response rates as those reported in registration trials for HCV-2 and HCV-3 pooled patients; pegylated interferon therapy failure was predicted by lack of rapid virological response.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments